[CARLSBG] QoQ TTM Result on 31-Dec-2012 [#4]

Stock
[CARLSBG] CARLSBERG BREWERY MALAYSIA BHD
Announcement Date
26-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- 1.66%
YoY- 15.33%
Quarter Report
Latest QR
Upcoming QR
CARLSBG's Result
CARLSBG's Financial Summary
View:
Show?
TTM Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 1,503,905 1,562,633 1,601,499 1,584,780 1,583,254 1,574,071 1,536,188 -1.40%
PBT 208,921 236,531 244,674 245,651 242,707 232,162 223,855 -4.49%
Tax -46,482 -51,332 -52,775 -51,898 -51,945 -54,207 -52,794 -8.13%
NP 162,439 185,199 191,899 193,753 190,762 177,955 171,061 -3.38%
-
NP to SH 160,354 182,974 189,805 191,633 188,512 176,303 169,578 -3.65%
-
Tax Rate 22.25% 21.70% 21.57% 21.13% 21.40% 23.35% 23.58% -
Total Cost 1,341,466 1,377,434 1,409,600 1,391,027 1,392,492 1,396,116 1,365,127 -1.15%
-
Net Worth 244,598 195,678 357,725 305,748 281,288 220,138 336,322 -19.11%
Dividend
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Div 192,621 192,621 177,486 177,486 206,458 206,458 206,458 -4.51%
Div Payout % 120.12% 105.27% 93.51% 92.62% 109.52% 117.10% 121.75% -
Equity
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Net Worth 244,598 195,678 357,725 305,748 281,288 220,138 336,322 -19.11%
NOSH 305,748 305,748 305,748 305,748 305,748 305,748 305,748 0.00%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin 10.80% 11.85% 11.98% 12.23% 12.05% 11.31% 11.14% -
ROE 65.56% 93.51% 53.06% 62.68% 67.02% 80.09% 50.42% -
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 491.88 511.09 523.80 518.33 517.83 514.83 502.44 -1.40%
EPS 52.45 59.84 62.08 62.68 61.66 57.66 55.46 -3.64%
DPS 63.00 63.00 58.05 58.05 67.55 67.55 67.55 -4.53%
NAPS 0.80 0.64 1.17 1.00 0.92 0.72 1.10 -19.11%
Adjusted Per Share Value based on latest NOSH - 305,748
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 491.88 511.09 523.80 518.33 517.83 514.83 502.44 -1.40%
EPS 52.45 59.84 62.08 62.68 61.66 57.66 55.46 -3.64%
DPS 63.00 63.00 58.05 58.05 67.55 67.55 67.55 -4.53%
NAPS 0.80 0.64 1.17 1.00 0.92 0.72 1.10 -19.11%
Price Multiplier on Financial Quarter End Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 -
Price 12.80 15.30 13.80 12.52 11.50 12.04 10.30 -
P/RPS 2.60 2.99 2.63 2.42 2.22 2.34 2.05 17.15%
P/EPS 24.41 25.57 22.23 19.98 18.65 20.88 18.57 19.97%
EY 4.10 3.91 4.50 5.01 5.36 4.79 5.38 -16.55%
DY 4.92 4.12 4.21 4.64 5.87 5.61 6.56 -17.43%
P/NAPS 16.00 23.91 11.79 12.52 12.50 16.72 9.36 42.91%
Price Multiplier on Announcement Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 18/11/13 27/08/13 29/05/13 26/02/13 29/11/12 28/08/12 30/05/12 -
Price 12.14 13.82 16.08 12.70 12.30 12.30 10.50 -
P/RPS 2.47 2.70 3.07 2.45 2.38 2.39 2.09 11.76%
P/EPS 23.15 23.09 25.90 20.26 19.95 21.33 18.93 14.34%
EY 4.32 4.33 3.86 4.94 5.01 4.69 5.28 -12.51%
DY 5.19 4.56 3.61 4.57 5.49 5.49 6.43 -13.29%
P/NAPS 15.18 21.59 13.74 12.70 13.37 17.08 9.55 36.16%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment